Century Therapeutics Inc. (NASDAQ: IPSC)
$1.0550
-0.0450 ( -4.96% ) 288.3K
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
Market Data
Open
$1.0550
Previous close
$1.1000
Volume
288.3K
Market cap
$88.43M
Day range
$1.0250 - $1.1800
52 week range
$0.9800 - $5.5100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Mar 11, 2024 |
4 | Insider transactions | 2 | Mar 11, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
8-k | 8K-related | 12 | Jan 19, 2024 |
8-k | 8K-related | 47 | Dec 11, 2023 |
4 | Insider transactions | 1 | Dec 06, 2023 |
8-k | 8K-related | 14 | Dec 06, 2023 |